Erythropoietin for patients with malignant disease
There is consistent evidence that the administration of erythropoietin reduces the risk for blood transfusions and the number of units transfused in cancer patients. For patient...
Publications
1 shownFrequent Co-Authors
Researcher Info
- h-index
- 1
- Publications
- 1
- Citations
- 75
- Institution
- University of Cologne
External Links
Identifiers
- ORCID
- 0000-0002-1890-1523
Impact Metrics
h-index
1
h-index: Number of publications with at least h citations each.